MDS/MPN CROSSOVER SYNDROMES
Clinical trials for MDS/MPN CROSSOVER SYNDROMES explained in plain language.
Never miss a new study
Get alerted when new MDS/MPN CROSSOVER SYNDROMES trials appear
Sign up with your email to follow new studies for MDS/MPN CROSSOVER SYNDROMES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to outsmart resistance in bone marrow cancer
Disease control Recruiting nowThis early-phase study tests a new way of giving two approved drugs (5-azacitidine and decitabine) to people with myelodysplastic syndromes (MDS) or related bone marrow disorders. The goal is to see if alternating low doses can overcome drug resistance and improve blood cell prod…
Matched conditions: MDS/MPN CROSSOVER SYNDROMES
Phase: EARLY_PHASE1 • Sponsor: Benjamin Tomlinson • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New registry aims to unlock secrets of rare blood cancers
Knowledge-focused Recruiting nowThis study is a long-term registry for people with myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Researchers will collect health records, surveys, and insurance data from 5,000 participants over at least five years to understand how the disease progresses an…
Matched conditions: MDS/MPN CROSSOVER SYNDROMES
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated May 26, 2026 08:31 UTC